EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Anticancer Activity of Corosolic Acid With Botanical Sources, Biopharmaceutical Profile, Mechanistic Insight, Toxicity, and Clinical Evidence

Mohammed Burhan Uddin, Md Nasimul Haque Shipon, Rituparna Biswas Suma, Md Anisur Rahman, Ali G Alkhathami, Emon Mia iD, Abul Bashar Ripon Khalipha, Khadija Akter, Md Sakib Al Hasan iD

Phytochemical Analysis · 2026

DOI: 10.1002/pca.70052 ↗

At a glance

Übersichtsarbeit in Phytochemical Analysis, 2026. Written by Mohammed Burhan Uddin and 8 co-authors. Institution: Department of Chemistry, York College of the City, University of New York, Jamaica, New York, USA. Major MEDLINE topics: Triterpenes, Antineoplastic Agents, Phytogenic, Neoplasms, Antineoplastic Agents. Cited 2 times so far (Crossref); 89 references. Funded by: King Khalid University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

Corosolic acid (CRS) is a naturally occurring pentacyclic triterpenoid primarily isolated from Lagerstroemia speciosa and other medicinal plants and has attracted growing interest because of its promising anticancer properties.

Objectives

This review provides a comprehensive synthesis of the botanical sources, biopharmaceutical characteristics, molecular mechanisms of action, toxicological profile, and clinical evidence associated with CRS. Materials and Methods A comprehensive literature search was conducted across major scientific databases, including PubMed, Google Scholar, Web of Science, ScienceDirect, SpringerLink, and Wiley Online, covering studies published up to April 2025. Peer‐reviewed articles investigating the anticancer activity, pharmacology, toxicity, pharmacokinetics, and clinical relevance of CRS were included.

Results

Preclinical evidence demonstrates that CRS exerts broad‐spectrum anticancer activity by inducing apoptosis, autophagy, ferroptosis, and cytotoxicity, while inhibiting tumor cell proliferation, metastasis, and survival signaling pathways, including PI3K/Akt/mTOR, NF‐κB, STAT3, and YAP/TAZ. Emerging data also highlight its immunomodulatory role, particularly through suppression of Th17‐mediated inflammatory responses, which may further contribute to its antitumor effects. Toxicological evaluations indicate that CRS possesses a favorable safety profile at therapeutic doses; however, its clinical translation is hindered by poor aqueous solubility and limited oral bioavailability. Recent advances in formulation strategies and structural modification approaches show potential for overcoming these limitations.

Conclusion

Overall, this review integrates current knowledge, identifies critical research gaps, and emphasizes the need for well‐designed clinical trials to establish CRS as a viable multitarget anticancer agent.

Subjects

MeSH terms (MEDLINE)

TriterpenesAntineoplastic Agents, PhytogenicNeoplasmsAntineoplastic AgentsHumansAnimalsApoptosis

Author keywords

anticancer activityapoptosisbiopharmaceutical profileclinical evidencecorosolic acid

Substances

Triterpenescorosolic acidAntineoplastic Agents, PhytogenicAntineoplastic Agents

Authors and institutions

  • Department of Chemistry, York College of the City, University of New York, Jamaica, New York, USA.
  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
  • Department of Pharmacy, Islamic University, Kushtia, Bangladesh.
  • BUBT Research Graduate School, Bangladesh University of Business and Technology (BUBT), Dhaka, Bangladesh.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Alor Dishari Research Organization, Dhaka, Bangladesh.

ORCID profiles: Emon Mia, Md Sakib Al Hasan

Funding

  • King Khalid University

Cite

APA

Uddin, M. B., Shipon, M. N. H., Suma, R. B., Rahman, M. A., Alkhathami, A. G., Mia, E., Khalipha, A. B. R., Akter, K., & Al Hasan, M. S. (2026). Anticancer Activity of Corosolic Acid With Botanical Sources, Biopharmaceutical Profile, Mechanistic Insight, Toxicity, and Clinical Evidence. Phytochemical Analysis. https://doi.org/10.1002/pca.70052

Vancouver

Uddin MB, Shipon MNH, Suma RB, Rahman MA, Alkhathami AG, Mia E, et al. Anticancer Activity of Corosolic Acid With Botanical Sources, Biopharmaceutical Profile, Mechanistic Insight, Toxicity, and Clinical Evidence. Phytochemical Analysis. 2026. doi:10.1002/pca.70052

BibTeX
@article{Uddin2026,
  author = {Uddin, Mohammed Burhan and Shipon, Md Nasimul Haque and Suma, Rituparna Biswas and Rahman, Md Anisur and Alkhathami, Ali G and Mia, Emon and Khalipha, Abul Bashar Ripon and Akter, Khadija and Al Hasan, Md Sakib},
  title = {Anticancer Activity of Corosolic Acid With Botanical Sources, Biopharmaceutical Profile, Mechanistic Insight, Toxicity, and Clinical Evidence},
  journal = {Phytochemical Analysis},
  year = {2026},
  doi = {10.1002/pca.70052}
}
Start for free →